We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Esure | LSE:ESUR | London | Ordinary Share | GB00B8KJH563 | ORD 1/12P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 279.60 | 279.40 | 279.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/8/2015 12:14 | Raising Premiums in the months ahead? It's very competitive out there. Why can't they control and reduce possible exuberant and even potential fraudulent pay outs? Insurance Companies are routinely fleeced on claims. | nick rubens | |
10/8/2015 11:23 | Depends on your timescale really. Reduced dividend but still a great dividend payer supported by vp being very cash generative. Well run with quality management. | gutterhead | |
10/8/2015 09:31 | I'm also out this morning. Increasing COR is a worry going forward. | dr biotech | |
10/8/2015 09:17 | 220p is what I have in mind...last few weeks this was giving a false sense of security by staying at highs whilst the overall markets were going down...news always get leaked and MM were suckering in longs... | diku | |
10/8/2015 08:18 | I'm out. I didn't like these numbers. This share is going to struggle for a while. May buy back lower down. A return to 220 is quite possible. | lord gnome | |
10/8/2015 08:12 | calm down dear this is just a profit warning? -- Gocompare(6) revenue broadly flat at GBP59.6m | opodio | |
10/8/2015 08:11 | H1 hit by substantial increase in motor claims - eps is down by 20% and dividend reduced by 16%. | masurenguy | |
29/7/2015 16:42 | This share moves in a strange mysterious way... | diku | |
16/7/2015 18:53 | This is a nice up trend. | yam114 | |
08/7/2015 16:24 | Year's high today while the FTSE is at year's low. | deadly | |
02/7/2015 11:12 | Well these have held up well. I guess they have little exposure to what is going on with Greece. No doubt the broker clowns will be update their recommendations and price targets just as we reach the top... | dr biotech | |
18/6/2015 09:17 | Do they really charge you £60 account closing fee?...is that why their dealing fees were so cheap?... | diku | |
15/6/2015 16:03 | My monitor is drowning in a sea of red. I know its not been a good few days but I'm pretty sure I will have been hit proportionally harder than the indexes. Apart from my index trackers of course which will at least match it.. | dr biotech | |
12/6/2015 15:22 | I had no further use for my iDealing account and tried to close it using the appropriate form. Nothing happened. Sent several e-mail asking what the delay was or if there was a problem. Not a single reply. On previous occasions I always got a quick reply if I had any questions but on this occasion not a single sign of life. I resorted to withdrawing all but the 60 quid account closing fee. Got my money but still no correspondents and I've now been locked out of my account so no access to my Tax certificates. If you're an iDealing customer you might want to ensure that you've got a back-up plan. | bikeaholic | |
11/6/2015 09:21 | The RSI is overbought so it may not be the best timing. I don't particularly follow that myself but I notice the information on my IG account. My average buy price here is about 230. They have done OK given I have had about 25p of dividends to include on that. Its a key holding for me. Got my house insurance renewal yesterday from the halifax. Premiums up by about 20%. I guess thats anecdotal evidence they are trying to push through rises. Needless to say I didn't accept their offer, got it much cheaper with more than. I should have tried this lot too really but they were not on the comparison website I use. | dr biotech | |
11/6/2015 08:50 | Bought in this morning at a tad under 260p. Enticed by the yield. These have shown remarkable strength recently in a weakening market, no doubt aided by the yield. I just hope I haven't bought a double top on the charts. | lord gnome | |
10/6/2015 14:19 | Well if anybody who takes over ESUR would maintain Peter Wood's services....so it would be a win win for him.... | diku | |
10/6/2015 12:42 | No chance of a bid. Peter Wood holds too many to allow this. I wonder when all the brokers that were saying sell a few months ago will adjust their price targets to the new sp? I feel more often now that brokers are more wrong than right. | dr biotech | |
10/6/2015 08:59 | Anybody think DLG could be looking in here for a possible takeout price of 330p while money is cheap and eliminate competition?...No Advice Intended... | diku | |
31/5/2015 10:29 | Just hope the general market sentiment doesn't spoil it....all too often it has a habit of doing that just when you think of an upside breakout... and the broker agenda is of good intentions!... | diku | |
29/5/2015 15:10 | Looks like a clear breakout now from the previous long term downtrend. | speedsgh | |
29/5/2015 15:09 | Can't see anything apart from this... Investment analysts at JPMorgan Chase & Co. lifted their target price on shares of Esure Group PLC (LON:ESUR) from GBX 280 ($4.33) to GBX 299 ($4.63) in a note issued to investors on Thursday. The firm currently has an “overweight | speedsgh | |
29/5/2015 14:39 | Any takeover rumours out there?.... | diku | |
27/5/2015 21:24 | 250p breakout... | diku |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions